Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Scarsbrook

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The British Journal of Radiology|September 14, 2012
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinomaR J D Prestwich, S Viner, G Gerrard, et al.
Clinical Radiology|December 4, 2014
Design and implementation of a web-based PET-CT reporting assessment and e-portfolio toolM Subesinghe, A R Goldstone, C N Patel, et al.
Clinical Radiology|June 9, 2007
Imaging manifestations of neck masses in the immunocompromised hostN Taylor, A F Scarsbrook, C P Conlon, et al.
Clinical Radiology|February 3, 2009
Established, emerging and future roles of PET/CT in the management of colorectal cancerR A Herbertson, A F Scarsbrook, S T Lee, et al.
The British Journal of Radiology|June 18, 2015
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinomaF Slevin, M Subesinghe, S Ramasamy, et al.
Clinical Radiology|April 8, 2022
Multimodality imaging in primary hyperparathyroidismA Zarei, S Karthik, F U Chowdhury, et al.
Clinical Radiology|May 19, 2012
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinomaR J D Prestwich, M Subesinghe, A Gilbert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2012
Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography?R J D Prestwich, J Sykes, B Carey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2018
Accuracy of Response Assessment Positron Emission Tomography-Computed Tomography Following Definitive Radiotherapy Without Chemotherapy for Head and Neck Squamous Cell CarcinomaM Arunsingh, S Vaidyanathan, K E Dyker, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|January 12, 2018
Accuracy of FDG PET-CT response assessment following radiotherapy alone for head and neck squamous cell carcinoma: Retrospective analysis of 45 patientsJ Philip, E Ermiş, F Slevin, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The British Journal of Radiology|September 14, 2012
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinomaR J D Prestwich, S Viner, G Gerrard, et al.
Clinical Radiology|December 4, 2014
Design and implementation of a web-based PET-CT reporting assessment and e-portfolio toolM Subesinghe, A R Goldstone, C N Patel, et al.
Clinical Radiology|June 9, 2007
Imaging manifestations of neck masses in the immunocompromised hostN Taylor, A F Scarsbrook, C P Conlon, et al.
Clinical Radiology|February 3, 2009
Established, emerging and future roles of PET/CT in the management of colorectal cancerR A Herbertson, A F Scarsbrook, S T Lee, et al.
The British Journal of Radiology|June 18, 2015
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinomaF Slevin, M Subesinghe, S Ramasamy, et al.
Clinical Radiology|April 8, 2022
Multimodality imaging in primary hyperparathyroidismA Zarei, S Karthik, F U Chowdhury, et al.
Clinical Radiology|May 19, 2012
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinomaR J D Prestwich, M Subesinghe, A Gilbert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2012
Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography?R J D Prestwich, J Sykes, B Carey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2018
Accuracy of Response Assessment Positron Emission Tomography-Computed Tomography Following Definitive Radiotherapy Without Chemotherapy for Head and Neck Squamous Cell CarcinomaM Arunsingh, S Vaidyanathan, K E Dyker, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|January 12, 2018
Accuracy of FDG PET-CT response assessment following radiotherapy alone for head and neck squamous cell carcinoma: Retrospective analysis of 45 patientsJ Philip, E Ermiş, F Slevin, et al.
Pageof 6